HEH（EHP）、H（DEHP）萃取铒（III）的动力学和机理的研究

萃取动力学的研究方法主要有：恒界面池法，充分混合法，单液滴法、生长液滴法，短时间相接触法和支撑液膜法。由于生长液滴法仪器简单，易于操作，且对于萃取速率快的体系尤为适宜，从而受到人们的注意。本文主要采用生长液滴法和充分混合法。本文分别研究了HEH（EHP）、H（DEHP）从盐酸介质中萃取E_r（III）的动力学和HEH（EHP）从硫酸介质中萃取E_rIII）的动力学，并讨论了萃取机理。实验表明，对于不同的萃取体系，其萃取机理不同。本论文做了以下几个方面的工作。1、HEH（EHP）从HCl介质中萃取E_r(III）的动力学和机理；2、HEH（EHP）从H_2SO_4介质中萃取E_r(III）的动力学和机理；3、H（DEHP）从HCl介质中萃取Er(III）的动力学。

Design and synthesis of near-IR luminescent mesoporous materials covalently linked with tris(8-hydroxyquinolinate) lanthanide(III) complexes

By using the bifunctional ligand, 8-hydroxyquinoline-functionalized organosilane (Q-Si), the new mesoporous material Q-MCM-41 covalently bonded with 8-hydroxyquinoline was synthesized. Through the ligand exchange reaction, the new near-infrared (NIR) luminescent mesoporous LnQ(3)-MCM-41 (Ln = Er, Nd, Yb) materials were prepared by linking the lanthanide quinolinate complexes to the ordered mesoporous Q-MCM-41 material. The LnQ(3)-MCM-41 materials were characterized by powder X-ray diffraction and N-2 adsorption/desorption, and they all show the characteristic mesoporous structure of MCM-41 with highly uniform pore size distributions.

Near-infrared emission from novel tris(8-hydroxyquinolinate)lanthanide(III) complexes-functionalized mesoporous SBA-15

A novel mesoporous material covalently bonded with 8-hydroxyquinoline (HQ) was synthesized (designated as Q-SBA-15). The 5-formyl-8-hydroxyquinoline grafted to.(3-aminopropyl)triethoxysilane, that is, alkoxysilane modified 8-hydroxyquinoline (Q-Si), was used as one of the precursors for the preparation of the Q-SBA-15 material. On the basis of the other function of the Q-Si of coordinating to lanthanide (Ln) ions, for the first time, the LnQ(3) complexes (Ln = Er, Nd, Yb) have been covalently bonded to the SBA-15 materials.

Structural characterization and luminescence studies of new lanthanide(III) complexes with nicotinic and isonicotinic acid N-oxides

Four new polymeric lanthanide(III) complexes of nicotinic acid N-oxide and isonicotinic acid N-oxide have been synthesized and structurally determined. In the isomorphous compounds [(Ln(L-1)(3) (H2O)(2))(n)]. 4nH(2)O(HL1 = nicotinic acid N-oxide; Ln = Eu, 1; Ln = Er, 2) the lanthanide(III) ions form infinite double chains along the b direction through the coordination of bridging carboxylate and N-oxide groups. The chains are cross-linked through hydrogen bonds between aqua ligands and uncoordinated N-oxide groups and between aqua ligands and lattice water molecules, to form a three-dimensional network. [(Eu(L-2)(2)-(H2O)(4))(n)](NO3)(n). nH(2)O (HL2 = isonicotinic acid N-oxide, 3) has a polymeric structure in which the europium (III) ions are connected into infinite chains by pairs of syn-syn carboxylate groups. Adjacent chains are interlinked by hydrogen bonds between aqua ligands and N-oxide groups to form a layer parallel to the (100) plane, and such layers are connected by hydrogen bonds between nitrate anions and aqua ligands, and between oxide groups and lattice water molecules, into a three-dimensional network. In [(Er-2(L-2)(4)(H2O)(10))](NO3)(2). H2O, 4, dinuclear units are inter-linked into a three-dimensional network through hydrogen bonding between aqua ligands and N-oxide groups of both bidentate bridging and unidentate L-2 ligands. Factors affecting the formation of coordination chains and dinuclear units are discussed. Luminescence properties of 1 and 3 have also been studied. (C) 1998 Elsevier Science Ltd. All rights reserved.

Synthesis and crystal structure of a polymeric erbium(III)-sodium(I) coordination complex of picolinic acid N-oxide

A new Er(III)-Na(I) coordination polymer of stoichiometry [NaEr2L5(H2O)(6)(NO3)](NO3). 3.5H(2)O (HL = picolinic acid N-oxide) has been synthesized and characterized by single-crystal X-ray analysis. Crystals are triclinic, P (1) over bar with a = 9.823(2), b = 12.453(2), c = 20.643(4) Angstrom; alpha = 98.49(3), beta = 101.40(3), gamma = 108.69(3)degrees; V = 2284(1) Angstrom(3); Z = 2. Of the two independent eight-coordinate erbium(III) ions in this complex, one is surrounded by four bidentate chelating L ligands, and the other by one bidentate chelating L ligand, four aqua ligands and two anti-carboxylate oxygen atoms from two neighboring [ErL4] units. The sodium(I) ion is in a distorted octahedral environment, being coordinated by a unidentate nitrate anion, three aqua ligands and two anti-carboxylate oxygen atoms from two adjacent [ErL4] units. The complex is built from zigzag chains of syn-anti carboxylate-bridged erbium(III) moieties directed in the a direction, which are cross-linked pairwise by aqua-bridged dimeric sodium(I) units. The resulting composite polymeric chains are further connected by hydrogen bonds to form a three-dimensional network.

TETRAKIS(MU-DL-ALANINE-O-O')OCTA-AGUADIERBIUM(III) HEXAPERCHLORATE

The structure of the title compound, [Er-2(C3H7NO2)(4)- (H2O)(8)](ClO4)(6), consists of dimeric [Er-2(DL-alanine)(4)-(H2O)(8)](6+) cations and perchlorate anions. The four alanine molecules act as bridging ligands linking two Er3+ ions through their carboxyl O atoms. Each Er3+ ion is also coordinated by four water molecules to complete eightfold coordination in a square antiprism fashion. The perchlorate anions and the methyl groups of the alanine ligands are disordered.

Mandelohydroxamic acid as ligand for copper(II) 15-metallacrown-5 lanthanide(III) and copper(II) 15-metallacrown-5 uranyl complexes

The formation of pentanuclear copper(ii) complexes with the mandelohydroxamic ligand was studied in solution by electrospray ionization mass spectrometry (ESI-MS), absorption spectrophotometry, circular dichroism and H-1 NMR spectroscopy. The presence of lanthanide(iii) or uranyl ions is essential for the self-assembly of the 15-metallacrown-5 compounds. The negative mode ESI-MS spectra of solutions containing copper(II), mandelohydroxamic acid and lanthanide(iii) ions (Ln = La, Ce, Nd, Eu, Gd, Dy, Er, Tm, Lu, Y) or uranyl in the ratio 5:5:1 showed only the peaks that could be unambiguously assigned to the following intact molecular ions: {Ln(NO3)(2)[15-MCuIIN(MHA)-5](2-)}(-) and {Ln(NO3)[15-MCCuIIN(MHA)-5](3-)}(-), where MHA represents doubly deprotonated mandelohydroxamic acid. The NMR spectra of the pentanuclear species revealed only one set of peaks indicating a fivefold symmetry of the complex. The pentanuclear complexes synthesized with the enantiomerically pure R- or S-forms of mandelohydroxamic acid ligand, showed circular dichroism spectra which were mirror images of each other. The pentanuclear complex made from the racemic form of the ligand showed no signals in the CD spectrum. The UV/ Vis titration experiments revealed that the order in which the metal salts are added to the solution of the mandelohydroxamic acid ligand is crucial for the formation of metallacrown complexes. The addition of copper(ii) to the solutions containing mandelohydroxamic acid and neodymium(iii) in a 5:1 ratio lead to the formation of a pentanuclear complex in solution. In contrary, titration of lanthanide(iii) salt to the solution containing copper(ii) and mandelohydroxamic acid did not show any evidence for the formation of pentanuclear species. ((c) Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2006)

Study of the luminescence of tris(2-thenoyltrifluoroacetonato)lanthanide(III) complexes covalently linked to 1,10-phenanthroline-functionalized hybrid sol-gel glasses

The solubility and uniform distribution of lanthanide complexes in sol-get glasses can be improved by covalently linking the complexes to the sol-gel matrix. In this study, several lanthanide beta-diketonate complexes (Ln = Nd, Sm, Eu, Tb, Er, Yb) were immobilized on a 1,10-phenanthroline functionalized sol-gel glass. For the europium(Ill) complex, a sol-gel material of diethoxydimethylsilane (DEDMS) with polymer-like properties was derived. For the other lanthanide complexes, the sol-gel glass was prepared by using a matrix of tetramethoxysilane (TMOS) and DEDMS. Both systems were prepared under neutral reaction conditions. High-resolution emission and excitation spectra were recorded. The luminescence lifetimes were measured. (c) 2004 Elsevier B.V. All rights reserved.

Persistent luminescence of SrAl2O4:Ce(III), Dy, Eu nanotubes, nanowires and core-shells for people with disabilities: nano-emergency

Este estudo transversal está focado na propriedade de luminescência persistente do aluminato de estrôncio co-dopado com cério (III), disprósio (III) e európio (II), SrAl2O4:Ce3+, Dy3+, Eu2+, em sistemas de sinalização de áreas de risco e emergências para pessoas com deficiências. Na área da ciência e engenharia dos materiais, foram desenvolvidos novos materiais com características nanométricas, nanotubos, nanoarames e nanobastões luminescentes de SrAl2O4:Ce3+, Dy3+, Eu2+ para aplicações na área da reabilitação e acessibilidade de pessoas com deficiências. Os nanotubos foram obtidos a partir de micro- e nano-partículas precursoras sintetizadas por reacção do estado-sólido e tratamento térmico de recozedura (1273-1473 K). Os nanoarames e nanobastões foram preparados por moagem, sonificação e recozedura (373 K). Novas nanocápsulas de aluminatos luminescentes dopados com cério (III) e encapsulados com TiO2 foram criadas de modo a obter-se materiais multifuncionais, designadamente com acção fotocatalítica antimicrobiana, antibacteriana e resistência à água. Tais aluminatos podem ser amplamente aplicados como superfícies higiénicas, auto-limpantes, em biomateriais, no domínio de medicamentos antibióticos, na formulação de vacinas, e com ênfase à aplicação em cerâmicas fotoluminescentes. As metodologias de obtenção de tais nanoestruturas de aluminato de estrôncio dopado com cério (III) e do seu encapsulamento, desenvolvidas no âmbito desta tese, são aplicáveis a diversos aluminatos dopados com outros iões lantanídeos (Ln consiste em La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Yb, Tm ou Lu) com a fórmula M(1-x-y)N2O4:Cex, Lny, onde M é Be, Mg, Ca, Sr ou Ba. Na área da oftalmologia, foi desenvolvido um equipamento médico para o diagnóstico de biofuncionalidade das células retinais fotoreceptoras, e como suporte à telemedicina oftalmológica. Este equipamento foi utilizado para realizar testes de visão cromática FM100HUE em fundo branco/preto para a personalização de materiais luminescentes. Os resultados demonstraram uma biofuncionalidade celular à visibilidade fotópica das cores em fundo preto superior no grupo de tratamento, composto por pessoas com retinopatia diabética (n=38), em comparação ao grupo de referência (n=38). Estes resultados sugerem a recomendação de materiais com fotoluminescência persistente (λem=485-555 nm), incluindo SrAl2O4:Ce3+, Dy3+, Eu2+, para o referido grupo de tratamento, em sinalização de emergência e em ambientes de baixa iluminação. Na área da arquitectura, foi proposta uma nova aplicação dos referidos nanomateriais luminescentes à base de SrAl2O4:Ce3+, Dy3+, Eu2+ em cerâmica de revestimento, tendo em vista a sua boa visibilidade e uso por pessoas com deficiências. Novos pavimentos, cerâmicos, fotoluminescentes, foram desenhados com propriedades multisensoriais (contraste táctil, sonoro e visual) e antimicrobianas, para pessoas portadoras de deficiências utilizarem, no escuro, com a prioridade de salvar vidas em emergências. Tais pisos, com relevos, podem ser combinados de modo a compor um sistema exclusivo de sinalização fotoluminescente multisensorial que possibilita a rápida evacuação mediante o uso de auxílios de mobilidade (e.g. bengala, cadeira de rodas, andadores, muletas). A solução integrada de tais inovações que potencializa a propriedade de luminescência persistente de SrAl2O4:Ce3+, Dy3+, Eu2+ de modo acessível para as pessoas com deficiências, pode contribuir para salvar vidas, no escuro, em emergências.

繡像二十四孝圖Xiu xiang er shi si xiao tu.Les vingt-quatre exemples de piété filiale, illustrés.

Au début du volume, une chanson. Gravé à la salle Fu wen, à Canton.

砥石齋二種曲Zhi shi zhai er zhong qu.Deux pièces du pavillon Zhi shi.

Contient : I詩扇記傳奇Shi shan ji chuan qi.Histoire d'un éventail avec une ode ; II夢裏緣傳奇Meng li yuan chuan qi.La fortune en songe ; III砥石齋韻品雜齣Zhi shi zhai yun pin za chu.Scènes diverses avec poésies du pavillon Zhi shi ; IV賞心幽品四種Shang xin you pin si zhong.Quatre scènes pour réjouir le fond du cœur ; V破牢愁Po lao chou .Le chagrin de l'appui brisé ; VI砥石齋散 (sic) 曲Zhi shi zhai san qu.Scènes diverses du pavillon Zhi shi

四書五經不贰字直音Si shu wu jing bu er zi zhi yin.Vocabulaire des caractères uniques des Quatre Livres et des Cinq Jing.

Ce vocabulaire donne seulement la prononciation au moyen d'homophones ; les caractères sont donnés dans l'ordre où ils paraissent dans le texte. Par Long Wan yu, surnom Xie tang, de Jin li ; préface de l'auteur (1808). Planches au pavillon Fu wen (1808).

薛院判醫案二十四種Xie yuan pan yi an er shi si zhong.Archives médicales du médecin impérial Xie.Nei ke.Médecine interne.

Contient : I十四經絡發揮Shi si jing luo fa hui.Examen des quatorze vaisseaux ; II難經本義Nan jing ben yi.Sens du Nan jing ; III本草發揮Ben cao fa hui.Traité de matière médicale ; IV平治會萃Ping zhi hui zui.Traité sur diverses maladies ; V家居醫錄內科摘要Jia ju yi lu nei ke zhe yao.Éléments de médecine interne ; VI明醫雜著Ming yi za zhu.Traités divers de médecins célèbres ; VII傷寒鈐法Shang han qian fa.Étude du traité de la fièvre typhoïde ; VIII敖氏外傷金鏡錄圖Ao shi wai shang jin jing lu tu.Traité de la langue dans la fièvre typhoïde ; IX原機啟微Yuan ji qi wei.Traité sur les maladies et les médicaments.You ke.Médecine infantile ; X保嬰撮要Bao ying tshoo yao.Traité général de médecine infantile ; XI錢氏小兒直（眞）訣Qian shi xiao er zhi (zhen) jue.Traité de médecine infantile ; XII陳氏小兒痘疹方論Chen shi xiao er dou zhen fang lun.Formules et traité pour la petite vérole chez les enfants ; XIII保嬰金鏡錄Bao ying jin jing lu.Traité de médecine infantile.Nü ke.Gynécologie ; XIV婦人良方Fu ren liang fang.Formules pour les maladies des femmes ; XV女科撮要Nü ke tshoo yao.Principes de gynécologie.Wai ke.Médecine externe ; XVI立齋外科發揮Li zhai wai ke fa hui.Examen de la médecine externe ; XVII外科心法Wai ke xin fa.Préceptes de médecine externe ; XVIII外科樞要Wai ke chu yao.Principes de médecine externe ; XIX外科精要Wai ke jing yao.Éléments de médecine externe ; XX癰疽神秘驗方Yong ju shen bi yan fang.Formules pour les furoncles ; XXI外科經驗方Wai ke jing yan fang.Formules éprouvées de médecine externe ; XXII正體類要Zheng ti lei yao.Exposé méthodique du corps humain ; XXIII口齒類要Kou chi lei yao.Exposé méthodique de la bouche et des dents ; XXIV癘瘍機要Li yang ji yao.Traité des ulcères

薛院判醫案二十四種Xie yuan pan yi an er shi si zhong.Archives médicales du médecin impérial Xie.Nei ke.Médecine interne.

Contient : I十四經絡發揮Shi si jing luo fa hui.Examen des quatorze vaisseaux ; II難經本義Nan jing ben yi.Sens du Nan jing ; III本草發揮Ben cao fa hui.Traité de matière médicale ; IV平治會萃Ping zhi hui zui.Traité sur diverses maladies ; V家居醫錄內科摘要Jia ju yi lu nei ke zhe yao.Éléments de médecine interne ; VI明醫雜著Ming yi za zhu.Traités divers de médecins célèbres ; VII傷寒鈐法Shang han qian fa.Étude du traité de la fièvre typhoïde ; VIII敖氏外傷金鏡錄圖Ao shi wai shang jin jing lu tu.Traité de la langue dans la fièvre typhoïde ; IX原機啟微Yuan ji qi wei.Traité sur les maladies et les médicaments.You ke.Médecine infantile ; X保嬰撮要Bao ying tshoo yao.Traité général de médecine infantile ; XI錢氏小兒直（眞）訣Qian shi xiao er zhi (zhen) jue.Traité de médecine infantile ; XII陳氏小兒痘疹方論Chen shi xiao er dou zhen fang lun.Formules et traité pour la petite vérole chez les enfants ; XIII保嬰金鏡錄Bao ying jin jing lu.Traité de médecine infantile.Nü ke.Gynécologie ; XIV婦人良方Fu ren liang fang.Formules pour les maladies des femmes ; XV女科撮要Nü ke tshoo yao.Principes de gynécologie.Wai ke.Médecine externe ; XVI立齋外科發揮Li zhai wai ke fa hui.Examen de la médecine externe ; XVII外科心法Wai ke xin fa.Préceptes de médecine externe ; XVIII外科樞要Wai ke chu yao.Principes de médecine externe ; XIX外科精要Wai ke jing yao.Éléments de médecine externe ; XX癰疽神秘驗方Yong ju shen bi yan fang.Formules pour les furoncles ; XXI外科經驗方Wai ke jing yan fang.Formules éprouvées de médecine externe ; XXII正體類要Zheng ti lei yao.Exposé méthodique du corps humain ; XXIII口齒類要Kou chi lei yao.Exposé méthodique de la bouche et des dents ; XXIV癘瘍機要Li yang ji yao.Traité des ulcères